Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
Abstract Background Duchenne muscular dystrophy (DMD) is a lethal muscle disease detected in approximately 1:5000 male births. DMD is caused by mutations in the DMD gene, encoding a critical protein that links the cytoskeleton and the extracellular matrix in skeletal and cardiac muscles. The primary...
Saved in:
Main Authors: | Fatima Amor (Author), Ai Vu Hong (Author), Guillaume Corre (Author), Mathilde Sanson (Author), Laurence Suel (Author), Stephanie Blaie (Author), Laurent Servais (Author), Thomas Voit (Author), Isabelle Richard (Author), David Israeli (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy
by: Ai Vu Hong, et al.
Published: (2021) -
Lessons Learned from Discontinued Clinical Developments in Duchenne Muscular Dystrophy
by: Theodora Markati, et al.
Published: (2021) -
Duchenne Muscular Dystrophy
by: J Gordon Millichap
Published: (1989) -
Theragnosis for Duchenne Muscular Dystrophy
by: Leonela Luce, et al.
Published: (2021) -
Muscular Fatigue in Duchenne Dystrophy
by: J Gordon Millichap
Published: (1995)